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ABSTRACT
          The effects of flavanoid-containing sport drinks on athletic performance, as reported in 
previous research, are equivocal. In short, these studies have not modeled the direct and indirect 
effects of flavanoid-containing drinks on specific athletic performance; thus they have not 
explored their effects on improving and maintaining specific athletic performance. The purpose 
of this study was to explore the effects of a flavanoid (i.e., quercetin) containing sport drink on 
rowing performance during the off-season. This study had two parts. Part one measured the 
chronic effects of FRS (free radical scavenger) on rowing performance, whereas part two 
measured the acute effects. Fifty male and female collegiate rowers between the ages of 18 to 25 
years were recruited and pair-matched on 2000 m rowing and then placed into either a 
supplement or placebo group for the first part of the study.  Baseline data included 500 m and 
2000 m rowing ergometer tests, 1RM bench press test, and vertical jump test. Subjects consumed 
a supplement or placebo drink twice a day for three weeks. After three weeks, subjects again 
reported to the lab for measurement of the aforementioned tests. In the second part of the study, 
subjects of the placebo group were pair-matched on 2000 m rowing ergometer performance and 
placed into the supplement or placebo group. This time, the supplement or placebo was given 
twice in the 150 min before testing 500m and 2000m rowing performances. Data were analyzed 
using 2×2 repeated measures ANOVA. Results from this study do not show any evidence for 
improvement in performances with the quercetin supplement. It can be concluded that acute 
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For an athlete, it is very important to optimize performance and avoid fatigue throughout 
competition. Athletes, seeking to boost performance, rely on practicing proper technique, 
increasing conditioning, and improving nutritional intake. There are many putative performance 
enhancing products available and use is often based on magazine advertisements, peer advice, or 
coach recommendation rather than objective information. A growing awareness of the synergy 
between diet and performance has fueled expanding interest in the role that micronutrients might 
play in improving physical performance. Mitigating fatigue, muscle soreness, free radical 
production, and homeostatic imbalance are all mechanisms that micronutrients might impact to 
affect performance. Amongst these, free radical production and muscle fatigue might be altered 
by an antioxidant (e.g., quercetin), now available in a sport drink. FRS (Free Radical Scavenger) 
is a sport drink containing quercetin, several other antioxidants, and caffeine. Claims for FRS are 
that it can improve athletic performance by maintaining availability of catecholamines during 
exercise by inhibiting catechol-O-methyltransferase (COMT), sparing vitamin C, and performing 
antioxidant functions, which may reduce oxidative damage and muscle fatigue.  
Metabolic stresses during high intensity endurance exercise and mechanical stresses 
during repeated lengthening (eccentric) muscle contractions result in generation of highly reactive 
oxygen species (ROS) that contain unpaired electrons (Kendall and Eston, 2002; McBride and 
Kraemer, 1999). ROS can accumulate in the working muscle inhibiting force production and 
contributing to acute muscle fatigue (Reid, 2001). ROS may reduce exercise performance by 
causing oxidative damage to adenosine triphosphate (ATPase) pumps, by significantly reducing 
calcium uptake by the sarcoplasmic retinaculum and by interfering with muscle excitation-
contraction coupling and thereby reducing muscle contractility (Kai, Zweier, and Becker, 1997; 
Lawler, Hu, and Barnes, 1998; Sen, 1995). Furthermore, muscle contractile proteins (fast and 
slow myosin heavy chains) and mitochondrial enzymes required for energy provision (e.g.,
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succinate dehydrogenase, cytochrome oxidase) appear to be susceptible to oxidative damage 
(Haycock, Peter, Harris, and Mantale, 1996). 
Oxidative stress that occurs as a result of increased ROS production can be avoided if 
ROS are quickly scavenged by either endogenous or exogenous antioxidants. Quercetin is an 
exogenous antioxidant contained in the FRS sport drink that may help to attenuate oxidative 
damage caused by ROS during exercise and recovery days. Studies show that antioxidant 
supplements improve exercise performance (Antoni et al., 2007). However, quercetin has not 
been studied in this regard. Other studies reported quercetin may enhance selected types of 
exercise performance (Holden and Mefferd, 2006). However, these findings cannot be 
generalized to other types of exercises. The present study will examine the potential of FRS (with 
quercetin) to attenuate fatigue and to improve exercise performance in rowers. 
Statement of Purpose
The purpose of the study was to determine if chronic and/or acute administration of FRS 
improves rowing performance in college-aged members of Division-III varsity crew team. 
Hypotheses
1) Chronic FRS supplementation will improve performance as measured by 500 and 2000 m 
rowing time trials and tests of power and strength (i.e., vertical jump and 1 RM bench press). 
2) Acute FRS supplementation will improve performance as measured by 500 and 2000 m 
rowing time trials and tests of power and strength (i.e., vertical jump and 1 RM bench press). 
Assumptions
The basic assumptions of the study include the following: 
1) The exercise protocol will be sufficient to cause generation of ROS and cause ROS-
related mechanisms of muscle fatigue to be activated. 
2) FRS will have antioxidant effects in working muscles that potentially affect performance. 
3) Three weeks supplementation of FRS will load enough antioxidant, allowing the 
scavenging of ROS produced during high intensity exercise. 
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4) Participants will put forth a full effort during all testing procedures. 
Delimitations
The delimitations of the study include: 
1) College-aged, well trained, male and female rowers were used as subjects. 
2) Rowing performance was measured using 500 m and 2000 m rowing ergometer tests. 
3) Vertical jump and 1 RM bench press were used as measures of power and strength. 
4) FRS (340ml) containing quercetin (325mg) was consumed twice daily for three weeks 
with no other dietary restrictions imposed. 
5) Chronic effects of FRS on rowing performance were examined on two testing sessions. 
6) Acute effects of FRS on rowing performance were examined on one testing session. 
Limitations
The limitations of the study include: 
1) The result may only be generalizable to well-trained, college-aged athletes but may not 
be applicable to sedentary individuals or those who are older or younger. 
2) These results may only be generalizable to middle distance indoor rowing performance 
and may not apply to on water or other types of exercise performance. 
3) The effects of individual diet, whether antioxidant rich or poor, was not controlled and 
may affect the results.  
Definition of Terms
Free radicals: Free radicals are atomic or molecular species with unpaired electrons on an 
otherwise open shell configuration. Free radicals are produced when the body processes oxygen 
in the mitochondria, generating reactive oxygen species (ROS) (Fielding and Meydani, 1997). 
Antioxidant (free radical scavengers): Is a molecule capable of slowing or preventing the 
oxidation of other molecules. Oxidation is a chemical reaction that transfers electrons from a 
substance to an oxidizing agent. Oxidation reactions can produce free radicals, which start chain 
reactions that damage cells. Antioxidants terminate these chain reactions by removing free radical 
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intermediates, and inhibit other oxidation reactions by being oxidized themselves (Maxwell, 
1995). 
Catecholamine: Catecholamines are chemical compounds, derived from the amino acid 
tyrosine containing catechol and amine groups. Some of them are biogenic amines. 
Catecholamines are water-soluble and are 50% bound to plasma proteins, so they circulate in the 
bloodstream. Catecholamines are well-known to play a major role in these adaptive processes. 
Indeed, in response to acute physical stress, adrenaline (A) and noradrenalin (NA) increase 
cardiac output, stimulate ventilation, and contribute to substrate mobilization and utilization 
(Galbo, Kjaer, and Secher, 1987). Plasma concentrations of A and NA are known to increase 
markedly during exercise, especially when the intensity is really high, such as during sprint 
exercise (Zouhal et al., 1998). 
Fatigue: Impairment in performance that leads to both the inability to maintain a certain 
level of force and an increased perception of task difficulty (Enoka and Stuart, 1992).
One-repetition maximum (1 RM): The maximum force one can apply throughout a single 
contraction. This experiment will use 1 RM bench press to measure maximum voluntary 
contraction (MVC) force (Swensen, Mancuso, and Howley, 1993). 
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Chapter 2 
Review of Literature 
When checking the effects of dietary supplements containing antioxidants on exercise 
performance and muscle fatigue, it is important to review previous related research. A number of 
studies have examined the ability of dietary supplement to combat oxidative muscle damage, but 
few studies have examined if they improve exercise performance. Fewer studies have examined if 
flavanoids can improve exercise performance, and generalization of these studies to all athletic 
populations is not clearly evidenced. Therefore, this chapter reviews, 1) Reactive Oxygen Species 
(ROS), 2) Generation of ROS and Exercise, 3) ROS and Muscle Fatigue, 4) Overview of 
Antioxidants, Vitamin C, and Vitamin E, 5) Flavanoids-quercetin, and 6) Antioxidants and 
Exercise Performance. 
Reactive Oxygen Species (ROS)
ROS are molecules that possess an unpaired electron. This characteristic gives them a 
short half-life as they are always searching to combine with another molecule to achieve a stable 
configuration. Superoxide, hydroxyl, alkoxyl, and peroxyl radical groups are key radicals in 
biological systems (Cooper, Vallard, Choueiri, and Wilson, 2002; McBride and Kraemer, 1999; 
Sen, 1995). Although hydrogen peroxide is not a ROS, it is generated by the superoxide radical. 
Hydrogen peroxide reacts with transition metals to form the hydroxyl radical. Hydroxyl is one of 
the most highly reactive and destructive radicals of the ROS family (McBride and Kraemer, 
1999; Packer, 1997). It will react with a variety of molecules that can potentially damage lipids, 
proteins, or nucleic acids (Packer, 1997). 
ROS generation is also associated with oxidation of lipoproteins (McKay and Blumberg, 
2002). Of particular interest to this study are the effects of ROS production during exercise on 
muscle membranes, proteins, ATPase pumps, and the integrity of the muscle cell following 
exercise.
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Generation of ROS and Exercise
Exercise is thought to generate ROS by three main pathways, which are reviewed below: 
ischemia-reperfusion, mitochondrial production, and the inflammatory response (McBride and 
Kraemer, 1999; Packer, 1997). 
Ischemia-Reperfusion: During intense exercise, blood flow is diverted from many organs 
(e.g., kidney and splanchnic regions) and non-working muscles. After cessation of exercise, 
normal blood flow is restored (Cooper et al., 2002; McBride and Kraemer, 1999; Packer, 1997). 
During reoxygenation of these organs and non-working muscles, xanthine oxidase activity 
increases, producing superoxide radicals (Cooper et al., 2002; Packer, 1997). 
Mitochondrial Production: Another proposed exercise-induced mechanism for generating 
ROS is mitochondrial metabolism (Cooper et al., 2002; McBride and Kraemer, 1999; Packer, 
1997). In this mechanism, electrons are leaked due to uncoupling at complexes I and III in the 
electron transport chain (ETC) (Leeuwenburgh and Heinecke, 2001; McBride and Kraemer, 
1999). The mitochondrial uncoupling proteins (i.e., UCP-2 and UCP-3) are also involved in 
mitochondrial flux, and their expression can be affected by certain diseases and disorders like 
diabetes, and ultimately responsible for mitochondrial ROS leakage. In healthy people under non-
stressful (low intensity) physiological conditions, UCP-2 and UCP-3 inhibit the release of ROS 
from the mitochondria (Orezechowski, 2003). However, mitochondrial uncoupling increases with 
increasing exercise intensity.  
Inflammatory Response: The inflammatory response has also been implicated in ROS 
production. This response is intentional and is part of the immune system response to injury 
(McBride and Kraemer, 1999). Neutrophils are inflammatory cells (macrophages and phagocytes) 
that migrate to the injured site, phagocytize damaged tissue or foreign material, and release 
(activate) proteolytic enzymes. However, they also release ROS via oxidative bursts. This release 
of ROS results in uncontrolled tissue damage (McBride and Kraemer, 1999). Oxidative bursts are 
likely secondary responses during recovery from intense anaerobic, moderate to intense aerobic 
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or eccentric exercise (MacIntyre, Sorichter, Mair, Berg and Mckenzie, 2001; McBride and 
Kraemer, 1999; Pyne, 1994). The inflammatory response has also been strongly linked to muscle 
soreness (Clarkson, 1997). 
ROS and Muscle Fatigue
Muscle fatigue has been associated with disturbances in Na+-K+ balance, changes in 
intracellular pH, accumulation of inorganic phosphate, impaired energy metabolism, 
accumulation of free radical species or ROS, and impaired intracellular Ca2+ handling and 
sensitivity (Fitts, 1994).  Accumulation of these reactive oxygen species has been suggested to be 
one of the main causes of fatigue during exercise (Reid, 2001). ROS may reduce exercise 
performance by causing oxidative damage to ATPase pumps, which significantly reduces calcium 
uptake by the sarcoplasmic retinaculum, thereby interfering with the excitation-contraction 
coupling process (Kai, Zweier, and Becker, 1997). Furthermore, muscle contractile proteins (fast 
and slow myosin heavy chains), and mitochondrial enzymes required for energy provision 
(succinate dehydrogenase, cytochrome oxidase) appear to be susceptible to oxidative damage 
(Haycock, Peter, Harris, and Mantale, 1996).  ROS may also affect the ability to develop the 
action potentials required for muscle contraction because damaged ATPase pumps cant return 
potassium back into the skeletal muscle cells, thereby decreasing excitability, which can lead to 
fatigue during exercise and ultimately impair performance (Lawler, Hu, and Barnes, 1998; Sen, 
1995). 
Overview of Antioxidants
Antioxidants are molecules capable of slowing or preventing the oxidation of other 
molecules. Oxidation is a chemical reaction that transfers electrons from a substance to an 
oxidizing agent. Oxidation reactions can produce free radicals, which start chain reactions that 
damage cells. Antioxidants terminate these chain reactions by removing free radical 
intermediates, and inhibit other oxidation reactions by being oxidized themselves (Maxwell, 
1995). 
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Dietary antioxidants may be able to detoxify the free radicals produced during exercise, 
which could otherwise result in damaging radicals (Dekkers, Van Doornen, and Kemper, 1996). 
These antioxidants are not generated by the body, and therefore must be constantly replenished 
through diet. Other antioxidants that are manufactured by the body can be bolstered through 
dietary supplementation of core antioxidants (Vasankari, Kujala, Rusko, Sarna, and Ahotupa, 
1997). These endogenous antioxidants include lipoic acid, glutathione, bilirubin, urate, albumin, 
ceruloplasmin, as well as the antioxidant enzymes superoxide dismutase, glutathione peroxidase, 
and catalase (Alessio and Blasi, 1997; Clarkson, 1995; Dekkers et al., 1996; Powers and Lennon 
1999). 
When exercising, the body processes up to 30 times more oxygen due to increased 
metabolism (Alessio and Blasi, 1997; Appel et al., 1997; Clarkson, 1995; Feilding and Meydani, 
1997). Although exercise training increases the production of the principal antioxidant enzymes, 
exercise seems to pertube the fine balance of the bodys defense system, rendering the tissue 
more susceptible to damage (Alesio, Goldfarb, and Cao, 1997; Clarkson, 1995; Dekkers et al., 
1996; Hong and Johnson, 1995; Ortenblad, Madsen, and Djurhuus, 1997; Sen, 1995). Some 
authors believe it is logical to expect that athletes could benefit from obtaining more dietary 
antioxidants in the diet to scavenge free radicals produced during exercise (Clarkson, 1995; Hong 
and Johnson, 1995; Ji, 1998). 
Vitamin C
Vitamin C is a water soluble vitamin. The role of vitamin C as an antioxidant is twofold; 
it directly scavenges superoxide, hydroxyl, and lipid hydroxide radicals, and it helps recycle 
vitamin E radicals by returning them to their reduced state (Packer, 1997). In the latter process, 
reduced vitamin C is converted to vitamin C radical. Recycling of vitamin C radical can be 
achieved by NADH semiascorbyl reductase or cellular thiols such as glutathione and 
dihydrolipoic acid (Sevanian, Davies, and Hochstein, 1985). Vitamin C is probably the most 
important antioxidant in extracellular fluid (Dekkers et al., and Peter, 1997). At the biochemical 
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level, the protective action of vitamin C may relate to its ability to neutralize ROS, which are 
produced by neutrophilic leukocytes during exercise induced phagocytosis (Peters, 1997). The 
concentration of vitamin C within neutrophils is approximately 50 times the extracellular 
concentrations indicating that large amounts are available to protect the neutrophil against the 
autotoxic activity of its own ROS (Peters, 1997). Thus vitamin C allows the neutrophil to do its 
primary role of phagocytosis, which theoretically should lead to a decreased incident of cellular 
damage. Inside cells, vitamin C reinforces the antioxidant effect of vitamin E by regenerating the 
active form of the fat-soluble vitamin after it has reacted with a free radical (Alesio et al., 1997; 
Dekkers et al., 1996; Rokitzki et al., 1994). In other words, vitamin C has a sparing effect on 
vitamin E, as well as on other endogenous antioxidants. It has been postulated that vitamin C 
supplementation, in combination with vitamin E supplementation, may be the most effective 
method for stopping the chain of free radicals produced in cells during exercise (Antoni et al., 
2007; Goldfarb, 1993; Peters, 1997). As well, various forms of stress can rapidly deplete vitamin 
C, therefore, athletes with reduced vitamin C status might benefit from vitamin C supplement. 
Vitamin C reportedly did not decrease markers of oxidative damage or improve recovery from 
unaccustomed exercise unless administered for at least 2 weeks prior to exercise stress, which 
then resulted in modest improvements in muscle soreness (Thompson et al., 2001, Thompson, 
Maynard, Morales, and Scordilis, 2003). Other well controlled studies showed that vitamin C did 
not affect exercise performance (Ashton et al., 1999; Clarkson, 1995). 
Vitamin E
Vitamin E is a fat soluble vitamin made up of tocopherols and is thought to be one of the 
most important antioxidants because of its association with cell membranes (Tiidus, Pushkarenko, 
and Houston, 1996). Among these -tocopherol is the best known and possesses the most potent 
antioxidant activity (Burton and Ingold, 1989, Janero, 1991). Because of its high lipid solubility, 
vitamin E is associated with lipid-rich structures such as mitochondria, sarcoplasmic retinaculum, 
and the plasma membrane. It protects against oxidative damage by acting directly with a variety 
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of oxygen radicals including singlet oxygen, lipid peroxide products, and the superoxide radical, 
to form a relatively innocuous tocopherol radical (Bieri, 1990). 
Vitamin E is important in energy production as it ensures that glucose is fully oxidized 
and adenosine triphosphate (ATP) is generated most efficiently (Rokitzki et al., 1994). Because 
vitamin E is a fat soluble vitamin, it has been suggested that athletes on a low fat diet may benefit 
from the use of supplements (Loft and Poulsen, 1997). Endurance training, in addition to 
increasing the oxidative capacity of muscles, improves the bodys enzymatic antioxidant defense 
(Alesio and Goldfarb, 1997; Brites et al., 1999, Dekkers et al., 1996; Jacob and Burri, 1996; 
Margaritis, Tessier, Richard, and Marconnet, 1997). However, muscle and other tissue consume 
vitamin E during increased physical activity (Appel et al., 1997; Avellini, Chiaradia, and Gaiti, 
1999). Therefore, many researchers suggest that vitamin E supplementation may be warranted to 
prevent free-radical damage induced by exercise (Dekkers et al., 1996; Oostenbrug et al., 1997; 
Rokitzki, 1994). Antoni et al. (2007) demonstrated that long term antioxidant diet supplements 
(e.g.,Vitamin E, C, and -carotene) often alternate the blood lactate concentration and production 
of ROS during exhaustive exercise, while improving the efficiency of aerobic metabolism. 
Similarly exercise-induced oxidative stress has been demonstrated in resistant-training 
athletes. McBride et al. (1998) divided 12 recreationally weight-trained men into two groups: one 
consumed 1200 IU vitamin E each day for two week, whereas the other group consumed 
cellulose-based placebo pills for two weeks. Vitamin E supplementation elicited a significant 
decrease in creatine kinase (CK) activity at 24 and 48 hrs post-exercise compared with the 
placebo group. These activities suggested that vitamin E supplementation may decrease muscle 
membrane disruption in addition to decreasing the level of ROS that occurs during exercise. 
Hence, it may be beneficial for both endurance-trained and strength-trained athletes to 
supplement their diets with vitamin E to prevent excess free-radical oxidative stress. 
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Flavonoids-Quercetin
Flavonoids are a large family of diphenylpropanes (over 4000 members have been 
identified) that are commonly found in plants consumed by humans. Family members include, 
but are not limited to; flavones, isoflavones, flavanones, anthocynins, and catechins (Das, 1994). 
Flavonoids have been reported to possess a wide variety of biological activities ranging from 
inhibition of inflammatory enzymes (e.g., lipoxygenase, cyclooxygenase, xanthine oxidase, 
NADH-oxidase, phospholipase, anti-tumoral, anti-viral, anti-mutagen, anti-inflammatory, anti-
ischemic, and anti-allergic activities (Cao, Sofic and Prior, 1997). Many of these biological 
effects are thought to be a result of the antioxidant capacity of flavanoids (Bors, Michel and 
Saran, 1994; Saija et al., 1995; Scalbert, Morand, Manach, and Remesy, 2002). Radical 
scavenging activities of flavonoids appear to vary greatly among family members, but include 
quenching of peroxyl, hydroxyl and superoxide radicals, as well as hydrogen peroxide and a 
variety of chemically generated radicals not naturally found in the body (Cao et al., 1997). 
Among the many flavonoids under investigation for their potential role in protecting against 
radical-mediated processes, is the polyphenolic flavonoid family, which includes quercetin. 
Quercetin is found in significant concentration in apple, tea, onion, nuts, berries, cauliflower and 
cabbage.  
Quercetin has many health promoting effects, including improving cardiovascular health 
and reducing risk for cancer and inflammatory effects cancers (Ferrandina et al., 1993; Mayo 
Clinic News 2001; Sabitha and Shyamaladevi, 1999; Scambia et al., 1991; Stefani et al., 1999). 
All these effects are thought to be caused by the strong antioxidant action of quercetin, which 
helps to combat free radicals molecules that can damage cells. The anti-inflammatory action of 
quercetin is caused by the inhibition of enzymes, such as lipoxygenase, and the inhibition of 
inflammatory mediators (Sato, Miyazaki, Kambe, Maeda, and Seo, 1997). Quercetin also inhibits 
the release of histamine from basophils and mast cells, which limits congestion (Pearce, Befus, 
and Bienenstock, 1984). Studies have shown that quercetin reduces the risk of prostate, ovary, 
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oral, and upper digestive tract cancers (Mayo Clinic News 2001; Ferrandina et al., 1993; Scambia 
et al., 1991; Sabitha and Shyamaladevi, 1999; Stefani et al., 1999). Quercetin also seems to 
reduce the production of uric acid by inhibiting the xanthine oxidase, thereby easing gout 
symptom (Sato et al., 1997). Studies have shown an improved lung function and lower risk of 
certain respiratory diseases (asthma and bronchitis) for people with high apple (rich in quercetin) 
intake (Tabak, Arts, Smit, Heederik, and Kromhout, 2001; Shaheen et al., 2001).  Quercetin can 
also potentially improve athletic performance by free radical scavenging, maintaining availability 
of catecholamines during exercise, sparing vitamin C, and performing antioxidant functions that 
can help to avoid oxidative damage and muscle fatigue. Holden and Mefferd (2006) shared that a 
quercetin containing dietary drink improved high-intensity cycling time-trial performance by 
increasing power output. 
Antioxidants and Exercise Performance
Antioxidant nutrient deficiencies are not widely reported among athletes (Clarkson, 
1995). However, it is conceivable that an antioxidant nutrient deficiency could result in an 
increased susceptibility to exercise-induced muscle damage by ROS and hence impaired exercise 
performance. Beek et al. (1990) have shown that a vitamin C deficiency impairs exercise 
performance in marginally deficient humans. It is very well understood that strenuous exercise 
may generate ROS to a level to overwhelm tissue antioxidant defense systems (Sen, 2001). 
Preventing muscle tissue damage during exercise training may help to optimize the training effect 
and eventual competitive sports performance. Results from studies examining the effects of 
vitamins and other antioxidants on oxidative stress have been conflicting (Goldfarb, Bloomer, and 
McKenzie, 2005; Mastaloudis, Traber, Carstensen, and Widrick, 2006; Packer, 1997; Rokitzki et 
al., 1994) supplemented endurance trained runners with 300 mg of RRR--tocopherol acetate and 
1000 mg of ascorbic acid, or a placebo, twice daily for six weeks. After the six weeks, the runners 
participated in an ultra-marathon run. Subjects performed a maximum voluntary contraction 
(MVC) prior to supplementation, one day pre-race, two hours post-race, and six days post-race. 
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Blood samples were also taken at 12 different times (prior to supplementation, one day pre-race, 
one hour pre-race, mid-race, immediately post-race, two hours post-race, and six days post-race). 
Plasma -tocopherol was increased in the supplemented group and remained unchanged in the 
control group. Ascorbic acid levels followed a similar trend. Increases in CK were significant 
from baseline, but not between the treatments. Post-race maximum voluntary contraction results 
were lower compared to baseline and no differences among treatments were found. In this case, 
supplementation with vitamins C and E did not attenuate the loss of muscle force or the increase 
in CK associated with ultra-marathon running. The authors suggested that a larger dosage of 
vitamin E may be needed to prevent the muscle damage found in this protocol. 
Nieman et al. (2001) supplemented experienced ultra-marathon runners with either a 
placebo or 1500 mg of vitamin C for seven days prior to an 80 kilometer (km) run. During the 
race, runners were given coded bottles of carbohydrate beverages (150 mg.l-1 with or without 
vitamin C). Saliva and blood samples were taken pre race, mid-race (32 km), and five minutes 
post-race. Isoprostanes (IsoP) were measured via mass spectrometry and lipid hydroperoxides 
were measured spectrophotometrically. Neutrophils and monocytes were determined using 
Enzyme-linked immunosorbent assay kits. They rose in both groups, but failed to reach 
significance. The level of serum vitamin C was significantly higher in the supplemented group. 
These data indicate that 1500 mg of vitamin C over seven days does not protect endurance 
athletes from oxidative stress. This lack of statistical significance could also be due to the timing 
of post-race sampling or perhaps vitamins C and E working synergistically. The study only asked 
participants to avoid foods with large amounts of vitamin C and to follow a high carbohydrate 
diet. Participants were also allowed to continue vitamin supplements as long as they did not 
provide more than 100% of the recommended daily values. Plasma vitamin E levels were not 
measured (Nieman et al., 2001). 
In contrast to the previous studies, some data show decrease in oxidative damage but 
there is no effect on exercise performance. Dekkers et al. (1996) concluded that dietary 
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supplementation with antioxidant vitamins has favorable effects on lipid peroxidation and 
exercise-induced muscle damage. They recommended vitamin supplementation to individuals 
performing regular heavy exercise. Evans (2000) noted that several antioxidants, including 
vitamin C and especially vitamin E decreased exercise-induced oxidative damage, which could 
help prevent muscle tissue damage. Takanami (2000) found that vitamin E contributes to 
preventing exercise-induced lipid peroxidation and possible muscle tissue damage. They 
recommended that athletes supplement with 100-200 milligrams of vitamin E daily to help 
prevent exercise induced oxidative damage. Ji (1999) indicated that the delicate balance between 
pro-oxidants and antioxidants suggests that supplementation of antioxidants may be desirable for 
physically active individuals under certain physiological conditions by providing a larger 
protective margin. In particular, he noted that the aging process lessens the exercise training-
induced improvement in natural antioxidant enzymes and suggests exercise training in older 
athletes might be assisted with antioxidant supplementation in attempts to optimize antioxidant 
defense. Sacheck and Blumberg (2001) concluded that the use of dietary antioxidants like vitamin 
E to reduce exercise-induced muscle injury have met with mixed success, which seems to be the 
prevailing viewpoint. All reviewers indicated more research is needed to address this issue and to 
provide guidelines for athletes. 
Summary
Literature in the study of antioxidants and exercise is inconsistent. Several possibilities, 
mainly related to methodology, exist for these inconsistencies. Studies evaluating vitamins E and 
C used different amounts, preparations and supplementation periods lasted anywhere from seven 
days to five months. The modes of exercise were running, cycling, or resistance exercise while 
some studies used a control group and some did not. Many of the variables recorded were 
measured with different assays and at different time periods. Finally, subjects ranged from non-
resistance trained females to elite male cyclists. 
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The results from Tsai et al. (2005) and other previously mentioned studies, suggested that 
oxidative damage due to ROS may be attenuated by antioxidant supplementation. ROS produced 
during exercise can accumulate in the working muscle, inhibiting force production and 
contributing to acute muscle fatigue (Reid, 2001). ROS may reduce exercise performance by 
causing oxidative damage to adenosine triphosphate (ATPase) pumps, by significantly reducing 
calcium uptake by the sarcoplasmic retinaculum, by interfering with muscle excitation-
contraction coupling and reducing muscle contraction (Kai et al., 1997). Quercetin is a flavonoid 





This chapter describes in detail the methodology of the study. Three major sections are 
included: (1) Subject Selection and Characteristics, (2) Study Design and Procedures, and (3) 
Statistical Analysis. 
Subject Selection and Characteristics
A total of 46 male and female collegiate rowers between the ages of 18 to 25 years served 
as subjects. Participants were recruited from the Ithaca College rowing team, through distribution 
of flyers (Appendix A) and a recruitment statement (Appendix B). At a preliminary group 
meeting, the project was explained to the subjects and their questions were answered. Those who 
wished to participate signed an informed consent (Appendix C). The Ithaca Colleges Human 
Subject Review Board approved the project. After informed consent was obtained, subjects filled 
out an exercise history (Appendix D) and health history questionnaire (Appendix E).  
Study Design and Procedures
The primary purpose of this study was to test the effects of FRS on exercise performance 
measures in well-trained rowers. The study had two parts and total of five testing sessions. Part 1 
measured the effect of chronic use of FRS on rowing performance, whereas Part 2 measured the 
acute effect of FRS on rowing performance. Subjects were instructed to maintain their usual 
training, racing, and dietary program throughout the course of the project and also were asked to 
refrain from any intense exercise 24 h prior to testing. A brief description of their previous days 
training and dietary habits were recorded before each testing session to ensure subject compliance 
to pretest instructions. 
Part 1: Chronic Effects of FRS
Testing session 1(Pre supplement): Day 1: All 60 subjects reported to the laboratory in 
the morning. Upon entry to the laboratory, anthropometric data such as height, weight, and body 
fat were measured. Each subjects body fat was estimated with a skinfold caliper according to the 
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methods of Pollock, Schmidt and Jackson (1980). In short, seven sites were measured twice. If 
measures at any site were 5% apart, a third measure was made. The mean of the two values in 
best agreement at the site was recorded as a sites skin-fold thickness. The means from each site 
were then summed and used to calculate body density, which was subsequently placed in Siris 
equation for percent fat determination (Siri, 1961).  All subjects completed a 10 to 15 min warm-
up designed by the head coach of the Ithaca College crew team. Warm-up included 5-7 min of 
rowing on a Concept II rowing ergometer (Digital Rowing Inc., Boston, USA) at a self-selected 
intensity, followed by five bursts of 10 repetitions of rowing strokes. After the warm-up, each 
subject completed 500 m rowing ergometer test on the ergometer followed by 2-3 min of active 
recovery at a low intensity. Approximately 30 min later, subjects completed the 2000 m rowing 
ergometer test, which was preceded by 5 min of warm-up at a self-selected pace and completed 
with a 2-3 min active recovery period. The following data were recorded during and at the 
completion of each ergometer test: HRmax, peak watts, average watts, and time. 
Testing session 2 (Pre supplement): Day 2: Twenty-four hours after the first testing 
session, subjects again reported to the lab so that their maximal vertical jump power and 1 RM for 
the bench press could be measured. Following 10-15 min of warm up, which included jogging on 
a treadmill, and arm ergometer cycling, the subjects then completed the vertical jump test. This 
test included three countermovement jumps with arm swing (Harman, Rosenstein, Frykman, and 
Rosenstein, 1990). Each jump was recorded to 0.1 cm and was separated by a rest period of 10 s. 
Jump height was measured with a portable hand-held computer unit connected to a contact timing 
mat (Newtest Oy, Finland). This technique has a validity and reliability similar to a force plate 
(Cronin, McNair, and Marshall, 2001). The height jump was recorded and this score was 
subsequently transformed into measures of peak and average power (W) using Harmans formula 
(Harman, Rosenstein, Frykman, Rosenstein, and Kramer, 1991). Fifteen minutes after the vertical 
jump test, the subjects then completed the 1 RM bench press test on a Cybex resistance training 
machine (Cybex international Inc., MA, USA), in accordance with the procedures of Swensen, 
Mancuso, and Howley (1993). In short, the test began with five repetitions with a light load        
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(~ 50% of estimated 1 RM). Approximately 2 min later, single repetitions were executed, starting 
with an initial load that was estimated as the subjects 1 RM as based on previous training. If the 
lift was completed, load was increased by 2.5 kg until the 1 RM was obtained. Each lift was 
separated by 2 min of rest. These 1 RM procedures have been shown to have test-retest reliability 
between 0.93 and 0.97 (Berger, 1970; OByrant, Byrd, and Stone, 1988). 
After completion of both day one and two testing sessions, subjects were pair-matched 
into the treatment or placebo groups based on their 2000 m ergometer time recorded in testing 
session 1. Participants were required to consume the liquid FRS or placebo supplement, twice a 
day with meals for three weeks, with one drink in the morning and one in the evening. FRS and 
placebo drinks were the same in color and flavor and not distinguishable.  
Testing session 3 (Post supplement): Day 1: After three weeks of intervention, subjects 
reported back to the laboratory where weight and body fat were measured as previously 
described. Subjects then completed 500 m rowing ergometer and 2000 m rowing ergometer test 
as described previously. 
Testing session 4 (Post supplement): Day 2: After 24 hours, the subjects reported to the 
laboratory for the measurement of vertical jump test and 1 RM bench press test. Tests were 
completed and data were recorded as previously described. 
Part 2: Acute Effects of FRS
Seventy-two hours after completion of test session four, the subjects in the placebo group 
were matched, based on 2000 m rowing ergometer performance, and divided into two groups, 
Group A and Group B. Both groups consumed their respective drinks twice on the day of testing 
with the first drink 150 min before and second drink just before the testing. 
Testing session 5:  The subjects reported to the laboratory for the measurement of 500 m 
and 2000 m ergometer tests. All the subjects went through the same testing protocols as 
previously described in testing sessions one and two. 
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Statistical Analysis
A double-blind, matched-pair protocol was used to assess the chronic effect of FRS on 
rowing performance. Consequently, the following dependent variables were analyzed with a 2 × 2 
repeated measures ANOVA: 500 m rowing time, 2000 m rowing time, vertical jump test and 1 
RM bench press.  A double-blind, matched-pair protocol was also used to assess the acute effect 
of FRS on rowing performance. In addition to a 2 x 2 repeated measures ANOVA, post-hoc 
independent and dependent sample t-tests were employed to analyze 500 m and 2000 m rowing 




The primary purpose of this study was to determine the effects of acute and/or chronic 
supplementation of a quercetin containing drink (FRS) on performance in rowers. Fifty subjects 
(26 males and 24 females) from a collegiate varsity rowing team volunteered for the study and 
were analyzed on these performance outcomes: 500 m row, 2000 m row, 1 RM bench press, and 
vertical jump test. Baseline data (Appendix F) were obtained for these variables and subjects 
were pair-matched on 2000 m rowing and then placed into supplement or placebo group. 
Following data collection, the results were analyzed and presented here in the following sections: 
1) Chronic Supplementation of FRS, 2) Acute Supplementation of FRS and 3) Summary. 
Chronic Supplementation of FRS
Three weeks of chronic loading was done for the supplement and placebo groups. The 
supplement group was provided with real FRS supplementation, whereas the placebo group 
was provided sham FRS supplementation for a period of three weeks. After three weeks: 1) 500 
m row, 2) 2000 m row, 3) 1 RM bench press, and 4) Vertical jump test variables were re-
measured. 
500 m Row: A 2 x 2 (Group x Time) ANOVA with repeated measure on time was used 
to look for differences in 500 m row time-trial performance between groups. Table 1 shows no 
significant Group x Time interaction (p = 0.464). Both placebo and supplement groups increased 
500 m  rowing performance across time as evidenced by a significant time main effect (p = 
0.006). This was likely the result of continued physical training by both groups. However, neither 
group had greater 500 m times as there was no difference between groups as demonstrated by 
non- significant group main effect (p = 0.100). These data shows that chronic FRS Loading did 
not improve 500 m time-trial performance. The descriptive data for the 500 m row time-trial can 
be seen in Table 2. 
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Table1. 500 m Row Time-Trial: ANOVA Summary Table  
                                                 SS                   DF                    MS                      F                      p
Group                                    0.013                  1                     0.013                 2.947              0.100 
Error (Group)                        0.098                22                     0.004                   
Time                                      0.004                  1                     0.004                 9.071              0.006* 
Error (Time)                          0.011                22                     0.000                  
Group x Time                        0.000                  1                     0.000                 0.556              0.464 
Error (Group x Time)            0.008                22                     0.000 
Note: * p < 0.05 
Table 2. 500 m Row Time-Trial Descriptive Data Table 
FRS                                          Placebo 
                                               Pre                    Post                  Pre                    Post 
Mean                                     1.387                 1.380               1.376                 1.367 
SD                                         0.092                 0.086               0.098                 0.088 
Note: Data are minutes. 
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2000 m Row: A 2 x 2 (Group x Time) ANOVA with repeated measures on time, was 
employed to inspect differences in 2000 m time-trial performance between supplement and 
placebo groups. Table 3 shows a significant Group x Time interaction (p = 0.009). Table 4 
displays independent sample t-test comparing the groups baseline 2000 m rowing times; there 
was no difference at baseline (p = 0.932). Similarly, there was no difference in 2000 m rowing 
time after supplementation (p = 0.176). Table 5 displays a significant time effect (p = 0.035) in 
2000 m rowing time across time in the placebo group, but not for the supplemental group (p = 
0.079). Thus, FRS supplementation does not improve 2000 m rowing performance across time. 
Tables 4 and 5 show the descriptive data for the 2000 m row. 
1 RM Bench Press: A 2 x 2 (Group x Time) ANOVA with repeated measure on time was 
employed to inspect for differences in 1 RM bench press performance between the groups. Table 
6 shows no significant Group x Time interaction (p = 0.171). There also was no significant time 
main effect found (p = 0.990); hence, the groups collectively did not improve across time. Neither 
group was different than the other as demonstrated by the non-significant group main effect (p = 
0.683). Thus, chronic loading with FRS supplementation does not improve 1 RM bench press 
performance. Table 7 shows the descriptive data for 1 RM bench press. 
Vertical Jump: A 2 x 2 (Group x Time) ANOVA with repeated measure on time was 
employed to inspect for differences in vertical jump performance between the groups. Table 8 
shows no significant Group x Time interaction (p = 0.689). Both groups increased vertical jump 
performance significantly across time as evidenced by significant time main effect (p = 0.013), 
but here was no group main effect (p = 0.799). These data show that chronic FRS 
supplementation does not improve vertical jump performance. Table 9 shows the descriptive data 
for the vertical jump. 
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Table 3. 2000 m Row Time-Trial ANOVA Summary Table  
                                                 SS                   DF                    MS                      F                      p
Group                                    0.235                  1                     0.235                 4.158              0.054 
Error (Group)                        1.244                22                     0.057                   
Time                                      0.154                  1                     0.154                 2.771              0.110    
Error (Time)                          1.227                22                     0.056                  
Group x Time                        0.311                  1                     0.311                 8.189              0.009*      
Error (Group x Time)            0.008                22                     0.000 
Note: * p < 0.05 
Table 4. 2000 m Row Time-Trial Post-hoc Independent Sample T-tests Table 
                    Group                     M                              SD                     T               DF                 p
                       T                        7.353                         0.603 
BL                                                                                                        -0.086         44               0.932       
                       P                        7.368                         0.591 
                       T                        7.387                         0.577 
PT                                                                                                         1.375          44               0.176      
                       P                        7.260                         0.493 
Note: Data are minutes; BL: Baseline; PT: Post-treatment; T: Treatment Group; P: Placebo Group 
Table 5. 2000 m Row Time-Trial Post-hoc Dependent Sample T-test Table 
             Group                      M                   SD                     T                       DF                     p
                BL                    7.353               0.602                          
 T                                                                                       -1.839                   22                   0.079          
                PT                    7.387               0.577     
                BL                    7.368               0.591                         
P                                                                                          2.244                   22                   0.035* 
                PT                    7.260               0.493 
Note: *p < 0.05; Data are minutes; T: Treatment Group; P: Placebo Group; BL: Baseline; PT: 
Post-treatment  
24
Table 6. 1 RM Bench Press ANOVA Summary Table  
                                                 SS                   DF                    MS                      F                       p
Group                                   36.494                   1                  36.494                 0.171               0.683 
Error (Group)                   4475.648                 21                213.126       
Time                                       0.002                   1                    0.002                 0.000               0.990  
Error (Time)                       302.381                 21                  14.399       
Group x Time                         9.776                   1                    9.776                 2.007               0.171  
Error (Group x Time)         102.266                 21                    4.870 
Table 7. 1 RM Bench Press Descriptive Data Table 
                                                         FRS                                           Placebo 
                                               Pre                    Post                    Pre                    Post 
Mean                                   66.63                65.95                    67.59                     68.28 
SD                                       16.65                18.55                    16.82           18.19 
Note: Data are kilograms 
Table 8. Vertical Jump ANOVA Summary Table 
                                                 SS                   DF                    MS                      F                      p
Group                                    7.102         1                     7.102                 0.081               0.799 
Error (Group)                  1849.148                21                   88.055                   
Time                                    51.011                  1                   51.011                 7.376              0.013*      
Error (Time)                     145.239                 21                    6.916                  
Group x Time                       0.920                   1                    0.920                 0.165               0.689     
Error (Group x Time)       117.330                 21                    5.587 
Note: *P< 0.05 
Table 9.Vertical Jump Descriptive Data Table 
                                                       FRS                                                Placebo 
                                            Pre                    Post                          Pre                       Post 
Mean                                  34.73                36.45                         34.87                    36.09 
SD                                        8.30                  7.45                         10.45                      9.71 
Note: Data are centimeters 
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Acute Supplementation of FRS
This section presents analyses of dependent variables of rowing performance in 
supplement vs. placebo groups after acute FRS supplementation. Drinks were provided to both 
supplement and placebo groups as described in the chronic treatment but with supplement given 
twice on testing day. FRS was administered 150 min before testing and again immediately prior 
to testing.  The performance variables measured in this acute FRS condition were: 1) 500 m Row 
and 2) 2000 m Row. 
500 m Row: A 2 x 2 (Group x Time) ANOVA with repeated measure on time was used 
to inspect for differences between groups in 500 m time-trial performance. ANOVA summary 
(Table 10) shows a significant Group x Time interaction (p = 0.045). As shown in Table 11, an 
independent sample t-test at baseline did not reveal a significant difference between groups (p = 
0.955) meaning the groups were similar before supplementation. The groups were also similar 
after supplementation (p = 0.898). Table 12 displays a dependent sample t-test comparison of 
baseline to post-supplementation 500 m row times for the placebo group and did not find a 
significant effect (p = 0.138). A similar comparison for the supplemental group also showed no 
significant improvement over time (p = 0.468). There is no evidence to conclude that acute 
loading with FRS supplementation improved 500 m time-trial performance.  
2000 m Row: A 2 x 2 (Group x Time) ANOVA with repeated measure on time was 
employed to inspect for differences in 2000 m rowing ergometer performance between 
supplement and placebo groups. Table 13 shows no significant Group x Time interaction (p = 
0.154). There was not any significant time main effect found (p = 0.071) meaning that the 
groups did not change from pre to post-supplementation. Finally, the acute groups were not 
different in 2000 m performance as no significant group main effect (p = 0.953) was obtained. 
There is no evidence to conclude that acute loading with FRS supplementation improved 2000 m 
time-trial performance. The descriptive data for 2000 m row time-trial can be seen in Table 14.   
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Summary
Three weeks of chronic FRS supplementation did not change the 500 m row, 2000 m 
row, 1 RM bench press, and vertical jump performances; the only significant change was seen in 
the placebo group for 2000 m row performance. Similarly, acute supplementation did not 
improve 500 m and 2000 m row performances. It can be concluded that acute and/or chronic 
supplementation of FRS does not have any effects on performance in rowers as tested. 
27
Table 10. 500 m Row ANOVA Summary Table 
                                                 SS                   DF                    MS                      F                    p
Group                                 6.25E-005              1                6.25E-005             0.010              0.922 
Error (Group)                            0.056               9                       0.006           
Time                                          0.000               1                       0.000             0.648               0.442    
Error (Time)                              0.002               9                       0.000                
Group x Time                            0.000               1                       0.000            5.413               0.045*      
Error (Group x Time)                0.001               9                7.81E-005 
Note: *p < 0.05 
Table 11. 500 m Row Post-hoc Independent Sample T-test Table 
                  Group                      Mean                    SD                     T                 DF                   p
                       T                        1.617                  0.154 
BL                                                                                                  -0.058            18                0.955     
                       P                        1.621                  0.157 
                       T                        1.627                  0.153 
PT                                                                                                    0.130            18                0.898     
                       P                        1.618                  0.156 
Note: Data are minutes; BL: Baseline; PT: Post-treatment; T: Treatment Group; P: Placebo Group 
Table 12. 500 m Row Post-hoc Dependent Sample T-test Table 
             Group                    Mean                 SD                    T                        DF                  p
              BL                        1.617               0.154                          
T                                                                                        -1.627                      9                0.138             
              PT                        1.627               0.153     
              BL                        1.621               0.157                         
P                                                                                         0.758                       9               0.468 
              PT                        1.618               0.156 
Note: Data are minutes; BL: Baseline; PT: Post-treatment; T: Treatment Group; P: Placebo Group 
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Table 13. 2000 m Rowing ANOVA Summary Table  
                                                 SS                   DF                    MS                      F                      p
Group                                   0.000                     1                  0.000                  0.004                0.953   
Error (Group)                       0.878                     9                  0.098                                     
Time                                     0.023                     1                  0.023                 4.201                 0.071             
Error (Time)                         0.049                     9                  0.005                          
Group x Time                       0.009                     1                  0.009                 2.425                 0.154        
Error (Group x Time)           0.033                     9                  0.004        
Table 14. 2000 m Row Descriptive Data Table 
                                                        FRS                                                Placebo 
                                              Pre                    Post                       Pre                     Post 
Mean                                    7.31                    7.23                      7.29                   7.27 
SD                                        0.66                    0.62                      0.56                   0.52 




The purposes of this study were to determine the effects of the chronic and acute FRS 
supplementation on performance in rowers during an off-season training period. Subjects were 
pair-matched, based on their 2000 m rowing performance, and were randomly placed in either a 
placebo or supplemental group to understand the effects of FRS on both rowing performance and 
muscular power. This chapter includes discussion on the performance effects of: a) Chronic 
Supplementation of FRS and, b) Acute Supplementation of FRS; it concludes with a summary. 
Chronic Supplementation of FRS
This present study found that three weeks of FRS supplementation did not improve 
performance in off-season workouts for collegiate male and female rowers, which does not 
support the contention that chronic FRS supplementation improves performance. Holden et al. 
(2006) previously examined a quercetin- containing compound in athletes performing cycling 
time trials. Their results demonstrated modest but significant improvements in performance after 
quercetin supplementation. Holden and Mefferd (2006) used a supplement like the present study 
containing 150 mg vitamin C, 300 mg of green tea, B vitamins, and quercetin. In contrast to the 
present study, Holden and Mefferd (2006) used six weeks of supplementation to obtain 
significant improvement in time trials, which suggests that length of supplementation may 
influence its ergogenicity. Apart from difference in duration of supplementation, the present study 
did not eliminate effects of other antioxidants. Thus, further investigation on how quercetin may 
act to enhance exercise performance is needed. 
The period of FRS supplementation may be critical to performance enhancing effects 
and, in the present study, FRS was taken for three weeks. Thompson et al. (2001, 2003) found 
that at least two weeks of antioxidant supplementation is necessary for modest loading and to 
combat against ROS produced during exercise. Holden and Mefferd (2006) used six weeks of 
loading with antioxidants to obtain performance enhancing effects by presumably avoiding 
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muscle fatigue caused by ROS produced during exercise. In the present study, after three weeks 
of supplementation, there was some trend for improvement in performance but it failed to reach 
statistical significance. It is possible that the reason for not reaching statistical significance might 
be the duration of supplementation or the selectivity of the exercise performance. Holden and 
Mefferd (2006) investigated a 30 km time-trial cycling performance as a measure of high 
intensity variable and found significant improvement in performance. 
Exercise-induced muscle damage occurs as a result of resistance exercise. Dekkers et al. 
(1996) concluded that dietary supplementation with antioxidant vitamins has favorable effects on 
lipid peroxidation and exercise-induced muscle damage. They recommended vitamin 
supplementation to individuals performing regular heavy exercise. In the current study, variables 
for measuring power were included as rowing is not only considered an endurance event but also 
considered a power sport. Bench press (1 RM) and vertical jump tests were administered to obtain 
measures of power but neither improved with FRS supplementation. Eccentric resistance exercise 
has been shown to increase markers of oxidative stress (Goldfarb et al., 2005) or may have no 
effects on oxidative stress (Lee et al. 2002). McBride et al. (1998) found two weeks of 
antioxidant (vitamin E) supplement reduces ROS levels during high intensity exercise. On the 
contrary, Mastaloudis et al. (2006) found no improvement in MVC after antioxidant 
supplementation was given for six weeks. Like Mastaloudis et al. (2006), the present study 
supports the notion that there is no significant improvement in power performance after chronic 
antioxidant supplementation. 
Some previous work showed a decrease in oxidative damage with no effect on exercise 
performance. Evans (2000) noted that several antioxidants, including vitamin C and especially 
vitamin E, decrease the exercise-induced oxidative damage, and may thereby prevent muscle 
tissue damage. Takanami et al. (2000) concluded that vitamin E contributed to preventing 
exercise-induced lipid peroxidation and muscle tissue damage, and they recommended that 
athletes supplement with 100-200 milligrams of vitamin E.  Sacheck and Blumberg (2001), 
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however, concluded that evidence for the use of dietary antioxidants like vitamin E to reduce 
exercise-induced muscle injury is equivocal and this seems to be the prevailing viewpoint. More 
research is needed to address the issue of exercise-induced tissue damage and supplementation to 
provide guidelines for athletes. 
In addition to potentially enhancing performance, quercetin and quercetin-containing 
drinks have also been shown to enhance immune function. Nieman et al. (2007) showed that 
quercetin supplementation reduced the incidence of upper respiratory tract infection in the weeks 
after three days of intensive cardiovascular exercise. Pearce (1984) reported quercetin can inhibit 
histamine release and may prevent congestion. In this regard, the correct dosage and timing of 
quercetin supplementation is not clearly defined. Whether the antioxidant and anti-inflammatory 
properties of quercetin are mechanistically linked, perhaps through redox perturbation, is 
currently unknown. In the current study, 320 mg of quercetin and other antioxidants (Vitamin A, 
C, E and catchins) supplementation were given twice daily. Athletes filled out a subjective cold 
questionnaire before and after the supplementation period. We did not find any improvement in 
cold symptoms with FRS supplementation. In fact, one subject in the FRS supplementation group 
dropped out of the study due to severe congestion. These cold-related data are mainly qualitative 
and no statistical significance is implied. 
Acute Supplementation of FRS
The present study also found that acute supplementation of FRS did not improve 500 and 
2000 m rowing time trial performance. It was speculated that acute supplementation may enhance 
performance in two ways: first, FRS contains 48 mg of caffeine, a well documented ergogenic 
aid. Second, as previously described, FRS contains the anti-oxidant quercetin. Oxidative stress is 
a well-defined outcome of acute physical activity (Powers et al., 1999). In the current study, acute 
FRS supplementation was given 2.5 h before, and immediately before exercise. The plasma half 
life of quercetin is 2 to 28 h and its action peaks about 2 h after consumption (Manach and 
Donavan, 2004). Acute FRS supplementation, as used in this study, did not improve performance 
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suggesting that either 48 mg of caffeine, the antioxidant load, or some combination of both 
variables were insufficient to act as ergogenic aids.  
Proven ergogenic doses of caffeine range from 250 to 500 mg, so it is not surprising that 
48 mg of caffeine, as found in FRS, did not improve performance. The acute effects of quercetin 
on exercise have not been studied. Indeed, the acute effects of antioxidants on exercise 
performance are not well studied. In contrast, the acute effects of antioxidants on various 
physiological variables following exercise are well studied. Hartmann et al. (1995) demonstrated 
that short-term vitamin E supplementation (800 mg administered 12 and 2 h before and 22 h post-
exercise) reduced DNA damage in peripheral leucocytes following exhaustive exercise. Others
have reported attenuated oxidative-stress when antioxidants are given before exercise (Goldfarb, 
1999; Goldfarb et al., 2005). In contrast, several studies did not demonstrate a reduction in 
markers of oxidative stress when antioxidants are given (Davison and Gleeson, 2006; Davison, 
Gleeson, and Phillips, 2007).  
Antioxidant supplementation, during or after exercise, may have little impact or actually 
enhance the oxidative-stress response (McAnulty et al., 2003; Thompson et al., 2003). High-dose 
vitamin C taken during an endurance run was reported to exacerbate the oxidative-stress response 
to lipid peroxidation (Nieman et al., 2002). Goldfarb et al. (2005) reported that the recovery of 
oxidative-stress markers to baseline might also be affected by exercise type, intensity, duration, 
training status, and diet. Antioxidant supplementation given for some time before exercise 
attenuated the interleuken-6 (IL-6) response (Fischer et al., 2004; Phillips, Childs, Dreon, 
Phinney, and Leeuwenburgh, 2003; Vassilakopoulos et al., 2003). In contrast, several studies 
showed that acute antioxidant treatment reduced oxidative stress but not the inflammatory 
response, suggesting these effects may be independent of each other (Davison and Gleeson, 
2006). Future research should examine FRS effects on exercise-induced oxidative damage. The 
present study only made an indirect assessment of damage and found no effect of acute 
supplementation on exercise performance. 
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Summary
The purposes of this study were to determine the effects of the chronic and acute FRS 
supplementation on performance in rowers during an off-season training period.  It was found 
that chronic FRS supplementation did not improve 500 and 2000 m rowing times, vertical jump 
or 1 RM bench press. Similarly, acute FRS supplementation did not improve 500 and 2000 m 
rowing time trial performance.  It is concluded that under the experimental conditions used in this 




Summary, Conclusions, and Recommendations 
This chapter provides an overview of the experiment and contains three sections: (1) 
Summary (2) Conclusions, and (3) Recommendations. 
Summary
The purpose of this study was to explore the effects of a flavanoid (i.e., quercetin) 
containing sport drink (i.e., FRS) on rowing performance. This study had two parts. Part 1 
measured the chronic effects of FRS on rowing performance, whereas Part 2 measured the acute 
effects. Forty-six male and female collegiate rowers, between the ages of 18 to 25 years, were 
randomly selected and pair-matched on their performance on 2000 m rowing ergometer test. They 
were then placed into either a supplement or placebo group for the first part of the study (i.e., 
chronic supplementation).   
Baseline data included 500 m and 2000 m rowing ergometer tests, 1RM bench press and 
vertical jump. Subjects were then advised to consume FRS sport drink (supplement or placebo) 
twice a day for three weeks.  
After three weeks, subjects again reported to the lab for the measurement of the 
aforementioned tests.  
In the second part of the study, subjects of the placebo group were pair-matched on 2000 
m rowing ergometer test and placed into a supplement group or placebo group. But this time, FRS 
was given twice before testing (i.e., first drink 150 min prior and second drink just prior to 
testing). Both 500m and 2000m rowing were measured. Data were analyzed using 2×2 repeated 
measures ANOVA and dependent sample t-test. 
Conclusions
1. Three weeks of chronic supplementation of FRS did not improve rowing or power 
performances. On the contrary, placebo group 2000 m row time improved significantly  
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(p < 0.05). This result should be interpreted with caution as this study was conducted during the 
off-season and subjects were training by themselves. 
2. Acute supplementation was also found ineffective, as both 2000 m and 500 m row tests 
failed to reach statistical significance. There was a significant time main effect, which means 
there was a trend for improvement across groups, but post-hoc independent and dependent sample 
analysis failed to reach statistical significance. It can be concluded that acute supplementation did 
not affect performance. 
Recommendations
Upon completion of the study, the following recommendations for further investigations 
are deemed appropriate:  
1. To further investigate the time of the training year in which the study is being conducted. 
The present study was conducted during an off-season without control of exercise routines. 
2. To see if all the athletes followed proper or an identical training program throughout the 
study. In the present study subjects were not monitored for their training program.   
3. In the present study, markers of oxidative stress were not included. Future studies should 
employ markers of oxidative stress to more conclusively examine the relationship between FRS 
supplementation and oxidative stress.   
4. To compare effects of quercetin when administered exclusively versus combined with 
other flavanoids and caffeine.
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Would you like to participate in a research project that is examining the effect of querectin 
containing free radical scavenger (FRS) sport drink on performance in rowers? The Company 
claims that this drink has performance enhancing effects if it is consumed for several weeks. 
Minimum of 1 year of competitive rowing experience is required to participate in this project. 
Subjects already consuming FRS sport drink and those who are having allergy to certain dyes, or 
having diabetes, taking antibiotics should not participate in this project. This experiment requires 
you to consume the FRS drink twice a day for three weeks. If you participate, there will be a 
maximum of five laboratory sessions although some of you might only do four sessions. In these 
sessions, 500 m and 2000 m rowing, vertical jump and 1 RM bench press tests will be done in 
that order. Adequate rest periods will be given between tests. Each lab session will take less than 
two hours. Generally you should not experience any discomforts from participating in this project 
other than you might get fatigued or might have some muscle soreness the next day. Participation 
is voluntary and you can withdraw from the study at any time without penalty. You must be at 
least 18 years or over to participate. Laboratory sessions will be scheduled according to your 
availability and coachs advice. 
Do you have any question??? Would you like to read the informed consent form, which describes 
what will happen in greater detail? 
                        IC CREW TEAM!!! 
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Appendix B 
Subject Recruitment Statement 
Would you like to participate in a research project that is examining the effect of querectin 
containing free radical scavenger (FRS) sport drink on performance in rowers? The Company 
claims that this drink has performance enhancing effect if it is consumed for several weeks. This 
experiment requires you to consume the FRS drink twice a day for three weeks. If you participate, 
there will be a maximum of five laboratory sessions although some of you might only do four 
sessions. In these sessions, 500 m and 2000 m rowing, vertical jump and 1 RM bench press tests 
will be done in that order. Adequate rest periods will be given between tests. Each lab session 
will take less than two hours. Generally you should not experience any discomforts from 
participating in this project other than you might get fatigued or might have some muscle 
soreness the next day. Participation is voluntary and you can withdraw from the study at any time 
without penalty. You must be at least 18 years or over to participate. Laboratory sessions will be 
scheduled according to coachs advice and your availability. 
Do you have any question??? Would you like to read informed consent, which describes what 
will occur in greater detail? 
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Appendix C
Informed Consent Form for 
Participation in Human Subjects Research 
Ithaca College 
Purpose of study: 
The purpose of the study is to examine if chronic and acute administration of quercetin containing 
Free Radical Scavenger (FRS) sport drink improves athletic performance while reducing the 
incidence of muscle fatigue in college-aged members of a varsity crew team. 
Benefits of the study: 
Improving and maintaining sport performance is very important to all athletes. Muscle fatigue 
may occur due to oxidative damage through free-radicals produced during exercise. FRS is a 
sport drink formula, which contains several antioxidants including a flavanoid-quercetin. The 
manufacturer claims FRS improves athletic performance by scavenging those free radicals 
produced during the exercise. Large amounts of money are spent on various types of sport drink 
for an athlete to get an extra edge during the competition, but little scientific evidence exists to 
support the use of these drinks. The result of this project may give credence for chronic or acute 
FRS for enhancing rowing performance. Alternatively, we may find, use of this drink is not 
effective and not worth any expenses. 
What you will be asked to do: 
Testing will be done in five different sessions at the Exercise Physiology Laboratory and Ithaca 
College Boat House. Each visit will take approximately 1.5-2.0 hours. You will be asked to 
attend an orientation meeting to get full details of the study, be introduced to the testing 
procedures, and answer your questions. 500 m and 2000 m time trial rowing ergometer tests, 
vertical jump and maximum bench press tests will be measured as follow:1st part: Pre-
supplemental day 1: This will be your baseline measurements. Upon entry height, weight and 
body fat will be measured. After this, you will do your routine warm-up for 10-15 min and will 
start with a 500 m rowing ergometer time-trial, followed by cool-down for 2-3 min. After 
completing 500 m rowing, you will be given a rest for 30 min. After that, you will undergo 5 min 
of warm-up followed by 2000 m rowing ergometer time-trial and a cool-down for 2-3 min.On 
another day, there will be 2nd laboratory session to measure vertical jump and maximum bench 
press. For the vertical jump test, you will be given 3 trials and the best one will be recorded. For 
bench press, your maximum bench press will be recorded. After this testing, you will consume 
FRS drink twice a day for three weeks. One drink in the morning with breakfast or lunch and one 
drink in the evening with dinner. During this period of three weeks you will otherwise be 
continuing your routine work out plan. 
After three weeks, you will be scheduled for the 3rd and 4th laboratory session to assess the post-
supplement changes in aforementioned tests on two separate days. 
2nd Part: Some of you will be scheduled for laboratory session 5 and will be asked to consume 
FRS twice more in a 24 hour period. This will be the final laboratory session when we will again 
measure 500 m rowing, 2000 m rowing, vertical jump height, and maximum bench press tests.  
Risks: 
Your risks of participation are minimal and are no more than the risks faced during the each 
testing session. These include fatigue, soreness, and potential injuries, which always accompany 
heavy exercise. FRS is a commercially available beverage with no known adverse effects; 
however, adding anything new to your diet may cause some digestive problems. Although no 
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special medical arrangements have been made, in the event of injury, standard first aid will be 
available during each testing session. All emergency procedures will be followed if need arises. If 
outside care is warranted then 911 will be called. There is no compensation available for injury; 
you are responsible for all medical costs in such an event. 
If You Would Like More Information About the Study 
Please contact principal investigator, Ankit Trivedi, Dr. G. A. Sforzo to get more information 
about the study, or to get a copy of the results. 
Email/phone Ankit Trivedi- atrived1@ithaca.edu/ 607-591-9041 
Dr. G.A. Sforzo- sforzo@ithaca.edu / 607-274-3359 
Withdrawal from the Study 
You may stop participating or withdraw from this study at any time without any penalty. 
Confidentiality of the Data 
All collected data will be confidential and shared only in group form. The data files will be kept 
in the graduate office in the Center for Health Sciences at Ithaca College in a secure lockable 
cabinet. Computer files will be accessed only by the principal investigator with a password. Your 
name will not be used in a connection with this study.  
I have read the above and I understand its contents. I agree to participate in this study. I 
acknowledge that I am 18 years of age or older. I have received a copy of this consent for my 
own records. 
Name (Print): 
Signed (Sign): ____________________________                Date: _________________ 
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Appendix D 
Exercise History Questionnaire 
General Instructions: Please complete this form as much detail as possible. 
Name (please print): ________________________ 
Age: __________ Sex: ___________ Phone no: ____________________ 
Status (circle one):    FR    SO     JR     SR     GRAD     FAC/STAFF 
Please rate your exercise level on a scale of 1 to 5 (5 indicating very strenuous):______________ 
Do you start exercise program but then find you self unable to adhere to them? 
 Yes           No 
Do you currently exercise? 
Yes         No         
If yes, indicate the major Activities: 
__________________________________________________________ 
Enter duration of exercise/day: ___________       No. of days/week you exercise: ______ 
I have been doing the above mentioned/similar exercise for _______weeks/months/years now 
(Circle) 
Rate your perceived exertion during your current exercise program (check the corresponding 
box): 
    Light                      Fairly Light              Somewhat Hard                     Hard 
How long have you exercised on a consistent basis? _____ Months _____ Years 
Please indicate the types of equipment you enjoy using at IC fitness center: 
  Exercise Bike      Elliptical trainer            rower               Treadmill 
  Step machine    Cybex (variable resistance machine)    Free weights 
Use the following scale to rank your fitness goals: 
Extremely                                          Somewhat                                                            Not at all 
important                                            important                                                             important 
1               2               3               4               5               6               7               8               9               10 
______ Improve cardiovascular fitness                             ________ Body-fat weight loss 
______ Reshape or tone my body                                      ________Improve sport performance 
______ Improve mood and stress tolerance                       ________ Improve flexibility/Strength 
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Appendix E 
Health History Questionnaire 
Name __________________________________________ Date _________________________  
Street Address ___________________________________ City __________________________  
State ___________________________________________ Zip __________________________  
Phone (home) ____________________________________ (work) _______________________  
Sex    M    F     Age ___________       Date of Birth _____/_____/_____   Class Level _______  
Physicians Name _________________________________ Phone _______________________  
Address ______________________________________________________________________  
*** Person to Contact In Case Of Emergency *** 
Name ___________________________________________ Relationship _________________  
Home Ph ________________________________________ Work Ph _____________________ 
Do you now, or have you had in the past:                                                   YES   NO  
1. History of heart problems, chest pains or stroke?   ______ ______  
2. Increased blood pressure?      ______ ______  
3. Any chronic illness or condition?     ______ ______  
4. Difficulty with physical exercise?     ______ ______  
5. Advice from physician not to exercise?    ______ ______  
6. Recent surgery (in the last 12 months)?    ______ ______  
7. Pregnancy (now or within the last 3 months)?    ______ ______  
8. History of breathing or lung problems?    ______ ______  
9. Muscle, joint or back disorder, or any previous injury still affecting you?       ______ ______     
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10. Diabetes or thyroid condition?     ______ ______  
11. Cigarette smoking habit?      ______ ______  
12. Obesity (more than 20 percent over ideal body weight)?  ______ ______  
13. Increased blood cholesterol?      ______ ______  
14. History of heart problems in immediate family?   ______ ______  
15. Hernia, or any condition that may be aggravated by lifting weights? ______ ______  
16. Are you taking any medication or drugs?    ______ ______  
     If yes, please list:  _______________________________________  
17. Does your physician know you are participating in this exercise program?       ______ ______  
Sign: 
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Appendix F  
Raw Data 
Chronic Supplementation Raw Data (Supplementation Group) 
 PRE POST PRE POST    
Gender 500 m 500 m  (2) 2000 m 2000 m (2)
Male 1.38 1.42 6.63 6.4    
Male 1.38 1.38 6.35 6.4    
Male 1.48 1.45 6.78 6.67    
Male 1.51 1.53 6.83 6.92    
Male 1.5 1.5 6.63 6.63    
Male 1.5 1.47 6.95 6.92    
Male 1.5 1.5 6.8 6.8    
Male 1.52 1.48 6.72 6.65    
Male 1.52 1.52 6.97 6.87    
Male 1.52 1.53 7.13 7.1    
Male 1.55 1.57 7.95 6.9    
Male 1.53 1.53 7.97 6.88    
Male 1.6 1.58 7.62 7.57    
Female 1.6 1.57 7.15 7.57    
Female 1.77 1.75 7.63 7.62    
Female 1.72 1.68 7.68 7.67    
Female 1.8 1.78 7.72 7.72    
Female 1.75 1.72 7.72 7.63    
Female 1.77 1.75 7.8 7.75    
Female 1.85 1.77 7.95 7.93    
Female 1.93 1.85 7.98 7.93    
Female 1.77 1.77 8.03 8.03    
Female 1.92 1.88 8.48 8.35    
Mean 1.62 1.61 7.37 7.26  
SD 0.17 0.15 0.59 0.57    
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Appendix F continued 
Chronic Supplementation Power Data (Supplementation Group)  
PRE POST   PRE POST 
1 RM 1 RM (2) V.J V.J (2) 
97.7 99 40 40 
75.0 74.25 45 45 
93.2 94.5 39 41 
97.7 101.25 41 50 
79.6 74.25 44 41 
75.0 74.25 40 38 
81.8 83.25 45 46 
75.0 76.5 46 45 
75.0 78.75 34 38 
84.1 85.5 55 55 
75.0 92.25 47 42 
65.9 63 43 41 
65.9 65.25 39 41 
61.4 56.25 23 31 
43.2 45 23 28 
52.3 51.75 28 31 
52.3 49.5 25 25 
47.7 49.5 20 19 
54.6 56.25 21 23 
54.6 49.5 24 27 
50.0 49.5 30 31 
50.0 51.75 31 33 
47.7 49.5 19 19 
67.59 68.28 34.87 36.09 




























Appendix F continued 
Chronic Supplementation Raw Data (Placebo Group) 
 PRE POST PRE POST 
Gender 500 m 500 m (2) 2000 m  2000 m (2) 
Male 1.43 1.43 6.43 6.5 
Male 1.48 1.45 6.63 6.7 
Male 1.52 1.5 6.65 6.7 
Male 1.52 1.48 6.72 6.68 
Male 1.52 1.52 6.75 6.83 
Male 1.5 1.57 6.78 6.98 
Male 1.42 1.45 6.8 6.93 
Male 1.53 1.52 6.93 6.98 
Male 1.53 1.55 7.08 7.12 
Male 1.58 1.55 7.07 6.98 
Male 1.62 1.58 7.3 7.27 
Male 1.67 1.65 7.47 7.47 
Female 1.65 1.65 7.35 7.32 
Female 1.72 1.7 7.47 7.58 
Female 1.62 1.63 7.48 7.6 
Female 1.75 1.72 7.67 7.92 
Female 1.65 1.63 7.7 7.68 
Female 1.78 1.82 7.83 7.8 
Female 1.8 1.8 7.93 7.9 
Female 1.88 1.82 7.95 7.95 
Female 1.9 1.87 8.23 8.3 
Female 1.85 1.82 8.32 8.22 
Female 1.92 1.88 8.58 8.5 
Mean 1.65 1.63 7.35 7.39 
SD 0.15 0.14 0.60 0.58 
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Appendix F continued 
Chronic Supplementation Power Data (Placebo Group) 
PRE POST PRE POST 
1 RM 1 RM (2) V.J V.J (2) 
70.5 74.3 44 47 
75.0 76.5 39 35 
77.3 76.5 44 48 
90.9 96.8 44 44 
77.3 65.3 49 51 
93.2 96.8 40 43 
106.8 112.5 42 35 
65.9 65.0 33 38 
65.9 63.0 36 38 
63.6 67.5 37 37 
79.6 78.8 37 34 
59.1 58.5 26 34 
52.3 47.3 21 25 
75.0 72.0 37 36 
52.3 47.3 35 35 
63.6 60.8 34 34 
54.6 54.0 26 33 
52.3 51.8 30 28 
47.7 47.3 20 26 
47.7 42.8 25 26 
54.6 51.8 23 29 
40.9 45.0 42 46 
66.63 65.95 34.73 36.45 



























Appendix F continued 
Acute Supplementation Raw Data (Placebo Group) 
 PRE POST   PRE POST 
Gender 
500 m 500 m  
(Acute) 
2000 m 2000 m 
(Acute) 
Male 1.38 1.38 6.4 6.38 
Male 1.53 1.52 6.92 6.88 
Male 1.5 1.5 6.65 6.65 
Male 1.5 1.5 6.8 6.75 
Male 1.57 1.57 6.92 6.93 
Female 1.78 1.77 7.72 7.7 
Female 1.75 1.72 7.75 7.6 
Female 1.78 1.8 7.93 7.88 
Female 1.85 1.85 8.45 8.33 
Female 1.57 1.57 7.57 7.23 
Mean 1.62 1.62 7.31 7.23 
SD 0.16 0.16 0.66 0.62 
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Appendix F continued 
Acute Supplementation Raw Data (Supplementation Group) 










Male 1.42 1.42 6.42 6.5 
Male 1.45 1.47 6.67 6.65 
Male 1.47 1.52 6.93 6.98 
Male 1.53 1.53 6.87 6.9 
Male 1.53 1.52 7.1 7.1 
Female 1.75 1.75 7.62 7.39 
Female 1.68 1.67 7.67 7.67 
Female 1.72 1.75 7.63 7.62 
Female 1.85 1.87 7.93 7.93 
Female 1.77 1.77 8.03 7.95 
Mean 1.62 1.63 7.29 7.27 
SD 0.15 0.15 0.56 0.52 
